Cite
Panuzzo C, Volpe G, Cibrario Rocchietti E, et al. New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia. Oncoscience. 2015;2(10):880-91doi: 10.18632/oncoscience.260.
Panuzzo, C., Volpe, G., Cibrario Rocchietti, E., Casnici, C., Crotta, K., Crivellaro, S., Carrà, G., Lorenzatti, R., Peracino, B., Torti, D., Morotti, A., Camacho-Leal, M. P., Defilippi, P., Marelli, O., & Saglio, G. (2015). New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia. Oncoscience, 2(10), 880-91. https://doi.org/10.18632/oncoscience.260
Panuzzo, Cristina, et al. "New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia." Oncoscience vol. 2,10 (2015): 880-91. doi: https://doi.org/10.18632/oncoscience.260
Panuzzo C, Volpe G, Cibrario Rocchietti E, Casnici C, Crotta K, Crivellaro S, Carrà G, Lorenzatti R, Peracino B, Torti D, Morotti A, Camacho-Leal MP, Defilippi P, Marelli O, Saglio G. New alternative splicing BCR/ABL-OOF shows an oncogenic role by lack of inhibition of BCR GTPase activity and an increased of persistence of Rac activation in chronic myeloid leukemia. Oncoscience. 2015 Nov 11;2(10):880-91. doi: 10.18632/oncoscience.260. eCollection 2015. PMID: 26682280; PMCID: PMC4671955.
Copy
Download .nbib